Back to User profile » Dr Chengping Hu

Papers published by Dr Chengping Hu:

The Intrapleural Bridge Connection is One of the Reasons for Unknown Localized Pleural Adhesion

Gu Q, Deng X, Li Z, Wang J, Hu C, Lei S, Cai X

International Journal of General Medicine 2021, 14:1429-1435

Published Date: 20 April 2021

Poor prognosis of pulmonary sarcomatoid carcinoma with KRAS mutation and ALK fusion

Chen F, Gu Q, Hu C, Cai X, Lei S

OncoTargets and Therapy 2019, 12:3321-3325

Published Date: 1 May 2019

Epigallocatechin-3-gallate-induced vascular normalization in A549-cell xenograft-bearing nude mice: therapeutic efficacy in combination with chemotherapy

Deng P, Hu C, Xiong Z, Li Y, Jiang J, Yang H, Tang Y, Cao L, Lu R

Cancer Management and Research 2019, 11:2425-2439

Published Date: 27 March 2019

Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial

Wu YL, Xu CR, Hu CP, Feng J, Lu S, Huang Y, Li W, Hou M, Shi JH, Märten A, Fan J, Peil B, Zhou C

OncoTargets and Therapy 2018, 11:8575-8587

Published Date: 30 November 2018

Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung

Lu S, Li W, Zhou C, Hu CP, Qin S, Cheng G, Feng J, Wang J, Cseh A, Peil B, Gibson N, Ehrnrooth E, Zhang L

OncoTargets and Therapy 2018, 11:8565-8573

Published Date: 30 November 2018

Recurrence risk after preoperative biopsy in patients with resected early-stage non-small-cell lung cancer: a retrospective study

Hu CP, Jiang J, Li YY, Zhang CF, Zhang WX, Jiang HH, Gao Y, Zhuang W, Lei KB, Tang Y, Wan RJ

Cancer Management and Research 2018, 10:1927-1934

Published Date: 6 July 2018